How Europe fell behind on vaccines
A story looking at vaccine procurement in the EU and elsewhere. The article summarises the trade offs arising from the EU’s centralised approach in the following way — “EU countries stuck together even as the U.S. and the U.K. bought, approved and began injecting vaccines at a faster clip. The result: lower prices, with higher accountability for drugmakers, and shots for the whole of the EU — but also delays in delivery and rising tensions among EU member countries resentful about the tradeoffs.”